MORATTI, MATTIA
MORATTI, MATTIA
Borsisti
Expert insights on Hodgkin’s lymphoma development in an activated PI3K delta syndrome patient undergoing leniolisib treatment
2025 Conti, Francesca; Moratti, Mattia; Sabattini, Elena; Zinzani, Pier Luigi
Granulomatous lymphocytic interstitial lung disease in common variable immune deficiency: an in-depth clinical, immunological, functional and radiological exploration with a focus on its management, challenged by chronic CMV infection
2025 Moratti, M.; Schifino, G.; Baccelli, F.; Ferrari, S.; Magrini, E.; Bassi, M.; Guerrieri, A.; Zompatori, M.; Lanari, M.; Conti, F.
NEONATAL INVASIVE HERPES INFECTIONS. INBORN ERRORS OF IMMUNITY AND PHENOCOPIES AS PREDISPOSING FACTORS
2025 Valencic, I.; Moratti, M.; Conti, F.; Nanni, F.; Ancora, G.
Neuroinflammation in CTLA-4 Haploinsufficiency: Case Report of a New Variant with Remarkable Response to Targeted Therapy
2025 Baldini, L.; Del Vecchio, L.; Cerasi, S.; Fetta, A.; Moratti, M.; Bezzi, A.; Ferrari, S.; Di Dalmazi, G.; Rossi, S.; Toni, F.; Cordelli, D. M.; Lanari, M.; Conti, F.
Unraveling the Genetic Predisposition on Respiratory Infections: From Single Nucleotide Polymorphisms to Inborn Errors of Immunity
2025 Conti, F.; Moratti, M.; Cinicola, B. L.; Castagnoli, R.; Papa, R.; Federici, S.; Giardino, G.; Leonardi, L.; Sangerardi, M.; Soresina, A.; Marseglia, G. L.; Giudice, M. M. D.; Lanari, M.; Cancrini, C.; Lougaris, V.; Cardinale, F.
Report of the Italian Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome in the Target Therapy Era
2024 Barzaghi, F.; Moratti, M.; Panza, G.; Rivalta, B.; Giardino, G.; De Rosa, A.; Baselli, L. A.; Chinello, M.; Marzollo, A.; Montin, D.; Marinoni, M.; Costagliola, G.; Ricci, S.; Lodi, L.; Martire, B.; Milito, C.; Trizzino, A.; Tommasini, A.; Zecca, M.; Badolato, R.; Cancrini, C.; Lougaris, V.; Pignata, C.; Conti, F.
Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use
2023 Conti F.; Moratti M.; Leonardi L.; Catelli A.; Bortolamedi E.; Filice E.; Fetta A.; Fabi M.; Facchini E.; Cantarini M.E.; Miniaci A.; Cordelli D.M.; Lanari M.; Pession A.; Zama D.
Exploring Factors Influencing Changes in Incidence and Severity of Multisystem Inflammatory Syndrome in Children
2023 Castaldo P.; d’Alanno G.; Biserni G.B.; Moratti M.; Conti F.; Fabi M.; Lanari M.
How to: Diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial, and fungal infections
2022 Moratti M.; Conti F.; Giannella M.; Ferrari S.; Borghesi A.
Inborn errors of immunity underlying a susceptibility to pyogenic infections: from innate immune system deficiency to complex phenotypes
2022 Conti F.; Marzollo A.; Moratti M.; Lodi L.; Ricci S.
In‐Depth Immunological Typization of Children with Sickle Cell Disease: A Preliminary Insight into Its Plausible Correlation with Clinical Course and Hydroxyurea Therapy
2022 Giulietti G.; Zama D.; Conti F.; Moratti M.; Presutti M.T.; Belotti T.; Cantarini M.E.; Facchini E.; Bassi M.; Selva P.; Magrini E.; Lanari M.; Pession A.
Refractory immune thrombocytopenia successfully treated with bortezomib in a child with 22q11.2 deletion syndrome, complicated by Evans syndrome and hypogammaglobulinemia
2022 Conti F.; Gottardi F.; Moratti M.; Belotti T.; Ferrari S.; Selva P.; Bassi M.; Zama D.; Pession A.
SARS-CoV-2 infection and treatment in a cohort of patients with inborn errors of immunity
2022 Conti F.; Pacillo L.; Amodio D.; Rivalta B.; Moratti M.; Campoli C.; Zama D.; Corsini I.; Giancotta C.; Bernardi S.; Naviglio S.; Cicalese M.P.; Rabusin M.; Aiuti A.; Cancrini C.; Lanari M.; Viale P.; Palma P.; Pession A.; Finocchi A.
Immune cytopenias as a continuum in inborn errors of immunity: An in-depth clinical and immunological exploration
2021 Zama D.; Conti F.; Moratti M.; Cantarini M.E.; Facchini E.; Rivalta B.; Rondelli R.; Prete A.; Ferrari S.; Seri M.; Pession A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Expert insights on Hodgkin’s lymphoma development in an activated PI3K delta syndrome patient undergoing leniolisib treatment | Conti, Francesca; Moratti, Mattia; Sabattini, Elena; Zinzani, Pier Luigi | 2025-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | fimmu-1-1517543.pdf |
| Granulomatous lymphocytic interstitial lung disease in common variable immune deficiency: an in-depth clinical, immunological, functional and radiological exploration with a focus on its management, challenged by chronic CMV infection | Moratti, M.; Schifino, G.; Baccelli, F.; Ferrari, S.; Magrini, E.; Bassi, M.; Guerrieri, A.; Zomp...atori, M.; Lanari, M.; Conti, F. | 2025-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| NEONATAL INVASIVE HERPES INFECTIONS. INBORN ERRORS OF IMMUNITY AND PHENOCOPIES AS PREDISPOSING FACTORS | Valencic, I.; Moratti, M.; Conti, F.; Nanni, F.; Ancora, G. | 2025-01-01 | MEDICO E BAMBINO | - | 1.01 Articolo in rivista | - |
| Neuroinflammation in CTLA-4 Haploinsufficiency: Case Report of a New Variant with Remarkable Response to Targeted Therapy | Baldini, L.; Del Vecchio, L.; Cerasi, S.; Fetta, A.; Moratti, M.; Bezzi, A.; Ferrari, S.; Di Dalm...azi, G.; Rossi, S.; Toni, F.; Cordelli, D. M.; Lanari, M.; Conti, F. | 2025-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | - |
| Unraveling the Genetic Predisposition on Respiratory Infections: From Single Nucleotide Polymorphisms to Inborn Errors of Immunity | Conti, F.; Moratti, M.; Cinicola, B. L.; Castagnoli, R.; Papa, R.; Federici, S.; Giardino, G.; Le...onardi, L.; Sangerardi, M.; Soresina, A.; Marseglia, G. L.; Giudice, M. M. D.; Lanari, M.; Cancrini, C.; Lougaris, V.; Cardinale, F. | 2025-01-01 | INTERDISCIPLINARY PERSPECTIVES ON INFECTIOUS DISEASES | - | 1.01 Articolo in rivista | - |
| Report of the Italian Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome in the Target Therapy Era | Barzaghi, F.; Moratti, M.; Panza, G.; Rivalta, B.; Giardino, G.; De Rosa, A.; Baselli, L. A.; Chi...nello, M.; Marzollo, A.; Montin, D.; Marinoni, M.; Costagliola, G.; Ricci, S.; Lodi, L.; Martire, B.; Milito, C.; Trizzino, A.; Tommasini, A.; Zecca, M.; Badolato, R.; Cancrini, C.; Lougaris, V.; Pignata, C.; Conti, F. | 2024-01-01 | JOURNAL OF CLINICAL IMMUNOLOGY | - | 1.01 Articolo in rivista | 10875_2024_Article_1835.pdf; 10875_2024_1835_MOESM4_ESM.zip |
| Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use | Conti F.; Moratti M.; Leonardi L.; Catelli A.; Bortolamedi E.; Filice E.; Fetta A.; Fabi M.; Facc...hini E.; Cantarini M.E.; Miniaci A.; Cordelli D.M.; Lanari M.; Pession A.; Zama D. | 2023-01-01 | CELLS | - | 1.01 Articolo in rivista | cells-12-02417.pdf |
| Exploring Factors Influencing Changes in Incidence and Severity of Multisystem Inflammatory Syndrome in Children | Castaldo P.; d’Alanno G.; Biserni G.B.; Moratti M.; Conti F.; Fabi M.; Lanari M. | 2023-01-01 | PATHOGENS | - | 1.01 Articolo in rivista | pathogens-12-00997.pdf |
| How to: Diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial, and fungal infections | Moratti M.; Conti F.; Giannella M.; Ferrari S.; Borghesi A. | 2022-01-01 | CLINICAL MICROBIOLOGY AND INFECTION | - | 1.01 Articolo in rivista | - |
| Inborn errors of immunity underlying a susceptibility to pyogenic infections: from innate immune system deficiency to complex phenotypes | Conti F.; Marzollo A.; Moratti M.; Lodi L.; Ricci S. | 2022-01-01 | CLINICAL MICROBIOLOGY AND INFECTION | - | 1.01 Articolo in rivista | - |
| In‐Depth Immunological Typization of Children with Sickle Cell Disease: A Preliminary Insight into Its Plausible Correlation with Clinical Course and Hydroxyurea Therapy | Giulietti G.; Zama D.; Conti F.; Moratti M.; Presutti M.T.; Belotti T.; Cantarini M.E.; Facchini ...E.; Bassi M.; Selva P.; Magrini E.; Lanari M.; Pession A. | 2022-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-11-03037-v2.pdf; jcm-11-03037-s001.zip |
| Refractory immune thrombocytopenia successfully treated with bortezomib in a child with 22q11.2 deletion syndrome, complicated by Evans syndrome and hypogammaglobulinemia | Conti F.; Gottardi F.; Moratti M.; Belotti T.; Ferrari S.; Selva P.; Bassi M.; Zama D.; Pession A. | 2022-01-01 | PLATELETS | - | 1.01 Articolo in rivista | - |
| SARS-CoV-2 infection and treatment in a cohort of patients with inborn errors of immunity | Conti F.; Pacillo L.; Amodio D.; Rivalta B.; Moratti M.; Campoli C.; Zama D.; Corsini I.; Giancot...ta C.; Bernardi S.; Naviglio S.; Cicalese M.P.; Rabusin M.; Aiuti A.; Cancrini C.; Lanari M.; Viale P.; Palma P.; Pession A.; Finocchi A. | 2022-01-01 | PEDIATRIC ALLERGY AND IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| Immune cytopenias as a continuum in inborn errors of immunity: An in-depth clinical and immunological exploration | Zama D.; Conti F.; Moratti M.; Cantarini M.E.; Facchini E.; Rivalta B.; Rondelli R.; Prete A.; Fe...rrari S.; Seri M.; Pession A. | 2021-01-01 | IMMUNITY, INFLAMMATION AND DISEASE | - | 1.01 Articolo in rivista | Immunity Inflam Disease - 2021 - Zama - Immune cytopenias as a continuum in inborn errors of immunity An in‐depth.pdf; IID3-9-583-s001.docx |